Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancer.

× No keyword cloud information.

41 in total

1. Chemotherapy as an adjuvant to surgery in lung cancer.

Authors: K Karrer; N Pridun; H Denck
Journal: Cancer Chemother Pharmacol Date: 1978 Impact factor: 3.333

Review 2. Surgical treatment of lung cancer.

Authors: M S Bains
Journal: Chest Date: 1991-09 Impact factor: 9.410

3. Prospective study of 445 lung carcinomas with mediastinal lymph node metastases.

Authors: N Martini; B J Flehinger; M B Zaman; E J Beattie
Journal: J Thorac Cardiovasc Surg Date: 1980-09 Impact factor: 5.209

4. Critical analysis of neoadjuvant therapy for Stage IIIa non-small cell lung cancer [corrected].

Authors: J R Murren; A C Buzaid; W N Hait
Journal: Am Rev Respir Dis Date: 1991-04

5. ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent.

Authors: T Mitsudomi; S M Steinberg; H K Oie; J L Mulshine; R Phelps; J Viallet; H Pass; J D Minna; A F Gazdar
Journal: Cancer Res Date: 1991-09-15 Impact factor: 12.701

6. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

Authors: R Rosell; J Gómez-Codina; C Camps; J Maestre; J Padille; A Cantó; J L Mate; S Li; J Roig; A Olazábal
Journal: N Engl J Med Date: 1994-01-20 Impact factor: 91.245

7. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.

Authors: G M Strauss; J E Herndon; D D Sherman; D J Mathisen; R W Carey; N C Choi; V B Rege; C Modeas; M R Green
Journal: J Clin Oncol Date: 1992-08 Impact factor: 44.544

8. Adjuvant cancer chemotherapy after resection of carcinoma of the lung.

Authors: T W Shields; E W Humphrey; C E Eastridge; R J Keehn
Journal: Cancer Date: 1977-11 Impact factor: 6.860

9. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial.

Authors: R L Burkes; R J Ginsberg; F A Shepherd; M E Blackstein; M E Goldberg; P F Waters; G A Patterson; T Todd; F G Pearson; J D Cooper
Journal: J Clin Oncol Date: 1992-04 Impact factor: 44.544

10. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma.

Authors: N E Mills; C L Fishman; W N Rom; N Dubin; D R Jacobson
Journal: Cancer Res Date: 1995-04-01 Impact factor: 12.701

1 in total

Review 1. Management of lung cancer.

Authors: A Melville; A Eastwood
Journal: Qual Health Care Date: 1998-09

1 in total